Boothbay Fund Management’s Charles River Laboratories CRL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q4 | $2.05M | Buy |
|
|||||
|
2024
Q4 | – | Hold |
|
|||||
|
2024
Q3 | – | Hold |
|
|||||
|
2023
Q4 | – | Sell |
|
|||||
|
2023
Q3 | $451K | Buy |
|
|||||
|
2023
Q2 | – | Sell |
|
|||||
|
2023
Q1 | $877K | Buy |
|
|||||
|
2022
Q4 | $218K | Buy |
|
|||||
|
2022
Q3 | – | Sell |
|
|||||
|
2022
Q2 | $1.54M | Buy |
|
|||||
|
2022
Q1 | – | Hold |
|
|||||
|
2021
Q4 | – | Hold |
|
|||||
|
2021
Q3 | – | Sell |
|
|||||
|
2021
Q2 | $212K | Buy |
|
|||||
|
2020
Q2 | – | Sell |
|
|||||
|
2020
Q1 | $787K | Sell |
|
|||||
|
2019
Q4 | $2.21M | Sell |
|
|||||
|
2019
Q3 | $2.24M | Buy |
|
|||||
|
2016
Q4 | – | Sell |
|
|||||
|
2016
Q3 | $674K | Sell |
|
|||||
|
2016
Q2 | $714K | Sell |
|
|||||
|
2016
Q1 | $828K | Buy |
|
|||||
|
2015
Q4 | $498K | Buy |
|
|||||
|
2015
Q3 | $375K | Buy |
|
|||||
|
2015
Q2 | $220K | Buy |
|